Eupraxia Pharmaceuticals (EPRX) Tax Provisions (2024 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted quarterly Tax Provisions of -$13905.0 for Q1 2026, down 397.67% year-over-year from $4671.2 in Q1 2025, and down 149.15% quarter-over-quarter from -$5581.0 in Q2 2025.
Eupraxia Pharmaceuticals (EPRX) Tax Provisions (2024 - 2026) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has reported Tax Provisions for 3 consecutive years, with -$13905.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions fell 397.67% year-over-year to -$13905.0; the TTM figure through Mar 2026 stood at -$17280.0 (changed N/A YoY), while the FY2025 annual figure was $19091.0, up 958.26% from the prior year.
- Tax Provisions retreated to -$13905.0 in Q1 2026 per EPRX's latest filing, from -$5581.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $5000.0 in Q2 2024 and bottomed at -$13905.0 in Q1 2026.
- Historically, Tax Provisions has averaged -$4456.0 across 3 years, with a median of -$5000.0 in 2024.
- Annual changes were most pronounced in 2025 — Tax Provisions jumped 44.12% — and 2026, when it slumped 397.67%.
- Eupraxia Pharmaceuticals' Tax Provisions stood at $5000.0 in 2024, then sank by 211.62% to -$5581.0 in 2025, then slumped by 149.15% to -$13905.0 in 2026.
- Business Quant data shows EPRX's Tax Provisions at -$13905.0 in Q1 2026, -$5581.0 in Q2 2025, and -$2794.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Eupraxia Pharmaceuticals | 381.11 Mn | 379.51 Mn | - | -13,905.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,905.00 |
| Jun 30, 2025 | -5,581.00 |
| Mar 31, 2025 | -2,794.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | -5,000.00 |